Joseph J. Echevarria Elected To Pfizer’s Board Of Directors
June 25 2015 - 11:20AM
Business Wire
Pfizer Inc. today announced the election of Joseph J. Echevarria
to its Board of Directors, effective immediately. Mr. Echevarria
also was appointed to the Audit, Regulatory and Compliance and
Science and Technology Committees of Pfizer’s Board.
Mr. Echevarria, 58, retired as Chief Executive Officer (CEO) of
Deloitte LLP, a global provider of professional services, in August
2014. He had been with the firm for 36 years and served in various
leadership roles, including Deputy Managing Partner, Southeast
Region Audit Managing Partner, U.S. Managing Partner and Chief
Operating Officer. He was appointed CEO in 2011.
Mr. Echevarria serves as a Director of The Bank of New York
Mellon Corporation. He is a member of the President’s Export
Council and the Presidential Commission on Election Administration
and also serves as Chair of President Obama’s My Brother’s Keeper
Alliance. He serves on the Board of Trustees of the University of
Miami.
“We are pleased to have Joe Echevarria join Pfizer’s Board of
Directors. His expertise in international business and leadership
as well as his financial acumen will be an asset to Pfizer’s Board
and to the company,” stated Ian Read, Pfizer’s chairman and chief
executive officer. “With the addition of Joe to our Board, Pfizer
and its shareholders will continue to benefit from a breadth and
diversity of experience.”
About Pfizer Inc.
At Pfizer, we apply science and our global resources to bring
therapies to people that extend and significantly improve their
lives. We strive to set the standard for quality, safety and value
in the discovery, development and manufacture of health care
products. Our global portfolio includes medicines and vaccines as
well as many of the world's best-known consumer health care
products. Every day, Pfizer colleagues work across developed and
emerging markets to advance wellness, prevention, treatments and
cures that challenge the most feared diseases of our time.
Consistent with our responsibility as one of the world's premier
innovative biopharmaceutical companies, we collaborate with health
care providers, governments and local communities to support and
expand access to reliable, affordable health care around the world.
For more than 150 years, Pfizer has worked to make a difference for
all who rely on us. To learn more, please visit us at
www.pfizer.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150625005921/en/
Pfizer Inc.Media:Joan Campion, (212) 733-2798orInvestor:Ryan
Crowe, (212) 733-8160
Pfizer (NYSE:PFE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Sep 2023 to Sep 2024